INTRODUCTION: The genetic contribution to the development of bronchopulmonary dysplasia (BPD) in prematurely born infants is substantial, but information related to the specific genes involved is lacking. RESULTS: Genotype analysis revealed, after multiple comparisons correction, two significant single-nucleotide polymorphism (SNPs), rs3771150 (IL-18RAP) and rs3771171 (IL-18R1), in African Americans (AAs) with BPD (vs. AAs without BPD; q < 0.05). No associations with Caucasian (CA) BPD, AA or CA respiratory distress syndrome (RDS), or prematurity in either AAs or CAs were identified with these SNPs. Respective frequencies were 0.098 and 0.093 in infants without BPD and 0.38 for each SNP in infants with BPD. In the replication set (82 cases; 102 controls), the P values were 0.012 for rs3771150 and 0.07 for rs3771171. Combining P values using Fisher's method, overall P values were 8.31 × 10(-7) for rs3771150 and 6.33 × 10(-6) for rs3771171. DISCUSSION: We conclude that IL-18RAP and IL-18R1 SNPs identify AA infants at risk for BPD. These genes may contribute to AA BPD pathogenesis via inflammatory-mediated processes and require further study. METHODS: We conducted a case-control SNP association study of candidate genes (n = 601) or 6,324 SNPs in 1,091 prematurely born infants with gestational age <35 weeks, with or without neonatal lung disease including BPD. BPD was defined as a need for oxygen at 28 days.
INTRODUCTION: The genetic contribution to the development of bronchopulmonary dysplasia (BPD) in prematurely born infants is substantial, but information related to the specific genes involved is lacking. RESULTS: Genotype analysis revealed, after multiple comparisons correction, two significant single-nucleotide polymorphism (SNPs), rs3771150 (IL-18RAP) and rs3771171 (IL-18R1), in African Americans (AAs) with BPD (vs. AAs without BPD; q < 0.05). No associations with Caucasian (CA) BPD, AA or CA respiratory distress syndrome (RDS), or prematurity in either AAs or CAs were identified with these SNPs. Respective frequencies were 0.098 and 0.093 in infants without BPD and 0.38 for each SNP in infants with BPD. In the replication set (82 cases; 102 controls), the P values were 0.012 for rs3771150 and 0.07 for rs3771171. Combining P values using Fisher's method, overall P values were 8.31 × 10(-7) for rs3771150 and 6.33 × 10(-6) for rs3771171. DISCUSSION: We conclude that IL-18RAP and IL-18R1 SNPs identify AA infants at risk for BPD. These genes may contribute to AA BPD pathogenesis via inflammatory-mediated processes and require further study. METHODS: We conducted a case-control SNP association study of candidate genes (n = 601) or 6,324 SNPs in 1,091 prematurely born infants with gestational age <35 weeks, with or without neonatal lung disease including BPD. BPD was defined as a need for oxygen at 28 days.
Authors: Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham Journal: Am J Hum Genet Date: 2007-07-25 Impact factor: 11.025
Authors: Elizabeth J Short; H Lester Kirchner; George R Asaad; Sarah E Fulton; Barbara A Lewis; Nancy Klein; Sheri Eisengart; Jill Baley; Carolyn Kercsmar; Meeyoung O Min; Lynn T Singer Journal: Arch Pediatr Adolesc Med Date: 2007-11
Authors: A Hilgendorff; K Heidinger; A Pfeiffer; A Bohnert; I R König; A Ziegler; C Merz; G Frey; T Chakraborty; L Gortner; G Bein Journal: Genes Immun Date: 2007-09-27 Impact factor: 2.676
Authors: Michael F Seldin; Russell Shigeta; Pablo Villoslada; Carlo Selmi; Jaakko Tuomilehto; Gabriel Silva; John W Belmont; Lars Klareskog; Peter K Gregersen Journal: PLoS Genet Date: 2006-07-25 Impact factor: 5.917
Authors: Hui Wang; Krystal R St Julien; David K Stevenson; Thomas J Hoffmann; John S Witte; Laura C Lazzeroni; Mark A Krasnow; Cecele C Quaintance; John W Oehlert; Laura L Jelliffe-Pawlowski; Jeffrey B Gould; Gary M Shaw; Hugh M O'Brodovich Journal: Pediatrics Date: 2013-07-29 Impact factor: 7.124
Authors: Jingjing Li; Kun-Hsing Yu; John Oehlert; Laura L Jeliffe-Pawlowski; Jeffrey B Gould; David K Stevenson; Michael Snyder; Gary M Shaw; Hugh M O'Brodovich Journal: Am J Respir Crit Care Med Date: 2015-09-01 Impact factor: 21.405
Authors: Alida S D Kindt; Kai M Förster; Suzan C M Cochius-den Otter; Andreas W Flemmer; Stefanie M Hauck; Andrew Flatley; Juliette Kamphuis; Stefan Karrasch; Jürgen Behr; Axel Franz; Christoph Härtel; Jan Krumsiek; Dick Tibboel; Anne Hilgendorff Journal: Pediatr Res Date: 2022-05-20 Impact factor: 3.756
Authors: Katarzyna Kosik; Anna Sowińska; Agnieszka Seremak-Mrozikiewicz; Jasmine A Abu-Amara; Salwan R Al-Saad; Lukasz M Karbowski; Katarzyna Gryczka; Grażyna Kurzawińska; Marta Szymankiewicz-Bręborowicz; Krzysztof Drews; Dawid Szpecht Journal: Mol Cell Biochem Date: 2022-03-01 Impact factor: 3.396
Authors: Felix Blume; Holger Kirsten; Peter Ahnert; Trinad Chakraborty; Arnd Gross; Katrin Horn; Mohammad Reza Toliat; Peter Nürnberg; Eva-Maria Westenfelder; Wolfgang Goepel; Markus Scholz Journal: Pediatr Res Date: 2021-08-31 Impact factor: 3.953